Cybin Inc.
General ticker "CYBN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $154.3M (TTM average)
Cybin Inc. follows the US Stock Market performance with the rate: 2.0%.
Estimated limits based on current volatility of 4.6%: low 6.94$, high 7.60$
Factors to consider:
- Total employees count: 2 as of 2022
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [4.31$, 11.16$]
- 2026-03-31 to 2027-03-31 estimated range: [3.68$, 9.61$]
Short-term CYBN quotes
Long-term CYBN plot with estimates
Financial data
| YTD | 2025-03-31 |
|---|---|
| Operating Revenue | CA$0.00MM |
| Operating Expenses | CA$143.15MM |
| Operating Income | CA$-143.15MM |
| Non-Operating Income | CA$30.01MM |
| R&D Expense | CA$54.91MM |
| Income(Loss) | CA$-113.14MM |
| Profit(Loss)* | CA$-113.14MM |
| Stockholders Equity | CA$237.20MM |
| Assets | CA$258.62MM |
| Operating Cash Flow | CA$-101.30MM |
| Capital expenditure | CA$1.97MM |
| Investing Cash Flow | CA$-1.97MM |
| Financing Cash Flow | CA$20.20MM |
| Earnings Per Share** | CA$-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.